BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7528432)

  • 1. Signs and symptoms of benign prostatic hyperplasia in men screened for prostatic carcinoma.
    Bosch JL; Niemer AQ; Kirkels WJ; Schröder FH
    Prog Clin Biol Res; 1994; 386():97-107. PubMed ID: 7528432
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of site differences in voiding condition of elderly men-- comparison to results of mass screening for prostate diseases between the villages of Shimamaki-mura, Hokkaido and Satomi-Mura, Ibaraki].
    Masumori N; Tsukamoto T; Tanaka Y; Kumamoto Y; Ishikawa S; Akaza H; Koiso K
    Hinyokika Kiyo; 1996 Aug; 42(8):557-61. PubMed ID: 8889562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia. A review of diagnostic and treatment options.
    Pfeiffer GM; Giacomarra M
    Adv Nurse Pract; 1999 Apr; 7(4):31-6; quiz 37-8. PubMed ID: 10382383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mass screening of prostate in Shiribeshi area in Hokkaido--incidence and clinical symptoms of benign prostatic hypertrophy and prostatic carcinoma].
    Umehara T; Kumamoto Y; Mikuma N; Yamaguchi Y; Tsukamoto T; Miura T; Watanabe H; Ooe H
    Hinyokika Kiyo; 1990 Apr; 36(4):415-23. PubMed ID: 1696062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptoms and signs of benign prostate hypertrophy (BPH)].
    Imai K; Kurokawa K; Sekihara T; Suzuki T; Yamanaka H; Takahashi H; Mashimo T; Takahashi O; Kitaura K; Saruki K
    Hinyokika Kiyo; 1993 Jan; 39(1):15-22. PubMed ID: 7681620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uroflowmetry of males over 50 years old--analysis of the mass examination of the prostate].
    Takagi Y; Kumamoto Y; Yamaguchi Y; Yoshioka M; Yokoyama E; Hayashi K; Furuya S; Ogura H
    Hinyokika Kiyo; 1987 Sep; 33(9):1368-74. PubMed ID: 2449056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
    Gualdi GF; Polettini E; Casciani E
    Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening: an innovative approach to accrual of large numbers of patients with early stage disease.
    Levine PA; Urich V; Murphy B; Parzinski R
    Prog Clin Biol Res; 1986; 216():79-85. PubMed ID: 2425374
    [No Abstract]   [Full Text] [Related]  

  • 11. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
    Hall MC; Roehrborn CG; McConnell JD
    Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
    Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
    Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
    Kato M; Okada K
    Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current approach to the management of benign hypertrophy of the prostate].
    Abbou CC; Salomon L; Chopin D; Ravery V; Haillot O
    Ann Urol (Paris); 1996; 30(6-7):294-301; discussion 302-10. PubMed ID: 9092383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K; Marković BB
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign hypertrophy of the prostate (BHP) in France: a challenge in organization of care].
    Costa P
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():1-3. PubMed ID: 16649581
    [No Abstract]   [Full Text] [Related]  

  • 20. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.